Philip Levine

6.8k total citations
111 papers, 2.0k citations indexed

About

Philip Levine is a scholar working on Hematology, Physiology and Genetics. According to data from OpenAlex, Philip Levine has authored 111 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Hematology, 38 papers in Physiology and 24 papers in Genetics. Recurrent topics in Philip Levine's work include Blood groups and transfusion (63 papers), Erythrocyte Function and Pathophysiology (36 papers) and Blood disorders and treatments (11 papers). Philip Levine is often cited by papers focused on Blood groups and transfusion (63 papers), Erythrocyte Function and Pathophysiology (36 papers) and Blood disorders and treatments (11 papers). Philip Levine collaborates with scholars based in United States, France and United Kingdom. Philip Levine's co-authors include Marino Celano, Elizabeth A. Koch, Jonathan Gruber, David Staiger, Elizabeth A. Robinson, J. Fabricant, William Pollack, Jane White, Sen‐itiroh Hakomori and B. W. Calnek and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Philip Levine

100 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Levine United States 27 1.1k 645 389 293 253 111 2.0k
Mary H. McGinniss United States 20 630 0.6× 356 0.6× 283 0.7× 342 1.2× 953 3.8× 52 2.6k
Michael Courtney France 37 597 0.5× 76 0.1× 833 2.1× 1.5k 5.0× 223 0.9× 103 3.3k
J. Alexandra Rowe United Kingdom 38 460 0.4× 276 0.4× 232 0.6× 558 1.9× 2.0k 7.9× 79 4.6k
George Garratty United States 46 4.3k 3.9× 2.6k 4.0× 1.7k 4.3× 612 2.1× 1.2k 4.6× 221 7.1k
Abraham Karpas United Kingdom 32 408 0.4× 153 0.2× 305 0.8× 1.8k 6.1× 1.1k 4.4× 113 4.1k
Dapa A. Diallo Mali 29 707 0.6× 246 0.4× 161 0.4× 282 1.0× 480 1.9× 102 2.9k
Rosalind E. Howes United Kingdom 28 1.0k 0.9× 244 0.4× 354 0.9× 402 1.4× 489 1.9× 50 5.3k
Kathleen Toomey United States 24 299 0.3× 171 0.3× 132 0.3× 391 1.3× 41 0.2× 98 1.7k
S. G. Anderson Australia 21 90 0.1× 151 0.2× 74 0.2× 175 0.6× 260 1.0× 49 1.1k
Tore Godal Norway 36 164 0.1× 83 0.1× 210 0.5× 807 2.8× 1.1k 4.4× 150 3.9k

Countries citing papers authored by Philip Levine

Since Specialization
Citations

This map shows the geographic impact of Philip Levine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Levine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Levine more than expected).

Fields of papers citing papers by Philip Levine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Levine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Levine. The network helps show where Philip Levine may publish in the future.

Co-authorship network of co-authors of Philip Levine

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Levine. A scholar is included among the top collaborators of Philip Levine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Levine. Philip Levine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Panaccione, Remo, Édouard Louis, Jean‐Frédéric Colombel, et al.. (2024). P593 Efficacy of Risankizumab in Patients With Moderately to Severely Active Ulcerative Colitis by Prior Advanced Therapy Failure and Mechanism of Action: Post Hoc Analysis of the INSPIRE and COMMAND Phase 3 Studies. Journal of Crohn s and Colitis. 18(Supplement_1). i1146–i1148. 1 indexed citations
2.
Ashenfelter, Orley, David Zimmerman, & Philip Levine. (2002). Statistics and Econometrics from A to Z. 1 indexed citations
3.
Levine, Philip. (2002). So Ask. University of Michigan Press eBooks.
4.
Gruber, Jonathan, Philip Levine, & David Staiger. (1999). Abortion Legalization and Child Living Circumstances: Who is the "Marginal Child"?. The Quarterly Journal of Economics. 114(1). 263–291. 174 indexed citations
5.
Levine, Philip, et al.. (1991). Monoclonal Antipeptide Antibodies against Amino Acid Residues 1101-1106 of Human C4 Distinguish C4A from C4B. PubMed. 8(1). 33–42. 4 indexed citations
6.
Levine, Philip. (1984). The Discovery of Rh Hemolytic Disease. Vox Sanguinis. 47(2). 187–190. 4 indexed citations
7.
Levine, Philip. (1981). Don't Ask. University of Michigan Press eBooks.
8.
Levine, Philip. (1976). ILLEGITIMATE BLOOD GROUP ANTIGENS P1, A, AND MN (T) IN MALIGNANCY–A POSSIBLE THERAPEUTIC APPROACH WITH ANTI‐Tja, ANTI‐A, AND ANTI‐T. Annals of the New York Academy of Sciences. 277(1). 428–435. 17 indexed citations
9.
Levine, Philip, et al.. (1973). Hemolytic Anemia Associated with Rhnull but not with Bombay Blood. Vox Sanguinis. 24(5). 417–424. 34 indexed citations
10.
Ascari, W. Q., Philip Levine, & William Pollack. (1969). Incidence of Maternal Rh Immunization by ABO Compatible and Incompatible Pregnancies. BMJ. 1(5641). 399–401. 37 indexed citations
11.
Witter, R. L., B. W. Calnek, & Philip Levine. (1966). Occurrence of Lymphomatosis in Chickens Free of Resistance-Inducing Factor (RIF) Virus. Avian Diseases. 10(1). 32–32. 2 indexed citations
12.
Levine, Philip, et al.. (1965). A Second Example of —/— or Rhnull Blood. Transfusion. 5(6). 492–500. 43 indexed citations
13.
Vos, G. H., et al.. (1964). Relationship of a Hemolysin Resembling Anti‐Tja to Threatened Abortion in Western Australia. Transfusion. 4(2). 87–91. 9 indexed citations
14.
Levine, Philip, Richard E. Rosenfield, & Jane White. (1961). The first example of the Rh phenotype rGrG.. PubMed. 13. 299–305. 26 indexed citations
15.
Levine, Philip. (1958). The influence of the ABO system on Rh hemolytic disease.. PubMed. 30(1). 14–28. 74 indexed citations
16.
Levine, Philip & Elizabeth A. Robinson. (1957). Some Observations on the New Human Blood Factor Dia. Blood. 12(5). 448–453. 16 indexed citations
17.
Levine, Philip. (1956). BLOOD GROUPS AND IMMUNOGENETICS. RARE RED CELL GENOTYPES – SOME ILLUSTRATIVE CASES. Human Heredity. 6(4). 515–516.
18.
Levine, Philip, et al.. (1954). Rare Human Isoagglutinins and Their Identification. American Journal of Clinical Pathology. 24(3). 292–304. 49 indexed citations
19.
Matson, G. Albin, Elizabeth A. Koch, & Philip Levine. (1954). A study of the hereditary blood factors among the Chippewa Indians of Minnesota. American Journal of Physical Anthropology. 12(3). 413–426. 43 indexed citations
20.
ISEKI, Shoei, et al.. (1954). A Remarkable Family with the Rare Human Isoantibody Anti-Tja in Four Siblings: Anti-Tja and Habitual Abortion. Nature. 173(4416). 1193–1194. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary H. McGinniss Breakdown of academic impact, for papers by Michael Courtney Breakdown of academic impact, for papers by J. Alexandra Rowe Breakdown of academic impact, for papers by George Garratty Breakdown of academic impact, for papers by Abraham Karpas Breakdown of academic impact, for papers by Dapa A. Diallo Breakdown of academic impact, for papers by Rosalind E. Howes Breakdown of academic impact, for papers by Kathleen Toomey Breakdown of academic impact, for papers by S. G. Anderson Breakdown of academic impact, for papers by Tore Godal
Rankless by CCL
2026